DigestRedComo funciona
Red
/
Empresas
Ta
No verificado

Takeda Pharmaceutical Company Limited

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

41 Comunicados de prensa

Ver todos los comunicados de prensa
22/01/2026
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Industria
Takeda Announces U.S. Availability of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
05/01/2026
Industria
Oncología
Salud
Higiene alimentaria
Medicina - Varios
Farmacéutica
Biotecnología
Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV)
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
18/12/2025
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
06/12/2025
Mercado laboral
Eventos
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
07/11/2025
Eventos
Industria
Biotecnología
Sanidad
Salud
Farmacéutica
Medicina - Varios
Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
03/11/2025
Industria
VIH, SIDA y enfermedades autoinmunes
Farmacéutica
Salud
Medicina - Varios
New Phase 3 Data Show Takeda’s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
30/10/2025
Biotecnología
Farmacéutica
Salud
Oncología
Mercado de valores
Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
27/10/2025
Industria
Material médico sanitario
Higiene alimentaria
Medicina - Varios
Biotecnología
Sanidad
Farmacéutica
Salud
Oncología
HyHub™ and HyHub™ Duo Devices Now Available in the U.S. to Simplify HYQVIA® Infusion Preparation
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
22/10/2025
Mercado laboral
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
23/09/2025
Biotecnología
Salud
Sanidad
Farmacéutica
Asociaciones/Profesionales
Medio Ambiente/Ecología
20,000 + Takeda Employees Voted to Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems in 94 Countries
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0